Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LDL-apheresis in homozygous LDL-receptor-defective familial hypercholesterolemia: the Munich experience.

Atherosclerosis. Supplements - 29 Dec 2009

Keller Christiane

Abstract excerpt

23 patients, homozygotes for LDL-receptor defective familial hypercholesterolemia (FH), were diagnosed at our institute since 1960, eight of whom were heterozygous compounds. Three were lost to follow-up. Eight patients died at ages between 7 and 60 years due to cardiovascular complications, five from acute myocardial infarction, one from acute left heart failure due to severe aortic stenosis, and two from sudden...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autopsy
Share to Blood Component Removal
Share to Cardiovascular Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cause of Death

Share to Germany

Share to Homozygote

Share to Hyperlipoproteinemia Type II

Share to Receptors, LDL

Source

Identifiers

PMID: 20129369
DOI: 10.1016/S1567-5688(09)71805-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LDL-apheresis in homozygous LDL-receptor-defective familial hypercholesterolemia: the Munich experience.PMID 20129369Read ↗

Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolemia: an expert consensus statement from ERKNet and ESPNSemantic proximity Read ↗

Clinical practice recommendations on lipoprotein apheresis for children with homozygous familial hypercholesterolaemia: An expert consensus statement from ERKNet and ESPN.Semantic proximity Read ↗

A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry).Semantic proximity Read ↗

Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes.Semantic proximity Read ↗

Low-density lipoprotein apheresis in a patient aged 3.5 years.Semantic proximity Read ↗

Eight novel LDL receptor gene mutations among patients under LDL apheresis in Dresden and Leipzig.Semantic proximity Read ↗

Lipoprotein Apheresis for Lipoprotein(a)-Associated Cardiovascular Disease: Prospective 5 Years of Follow-Up and Apolipoprotein(a) Characterization.Semantic proximity Read ↗

Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France.Semantic proximity Read ↗

Autosomal recessive hypercholesterolemia in three sisters with phenotypic homozygous familial hypercholesterolemia: diagnostic and therapeutic procedures.Semantic proximity Read ↗

Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol.Semantic proximity Read ↗

Homozygous familial hypercholesterolemia with severe involvement of the aortic valve-A sibling-controlled case study on the efficacy of lipoprotein apheresis.Semantic proximity Read ↗

Treatment of homozygous familial hypercholesterolaemia in paediatric patients: A monocentric experience.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.